Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1205
Wound Care Market is poised to value over CAGR of over 7.5% during the forecast period 2022 to 2028. FutureWise Market Research has instantiated a report that provides an intricate analysis of Wound Care Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market. According to the research study conducted by FutureWise research analysts, the Wound Care Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Wound Care Market: • Wuhan Huawei Technology Co. Ltd. • Huizhou Foryou Medical Devices Co. Ltd. • DSHZ Science Technology Co. Ltd. • Smith and Nephew PLC • Convatec Inc. • Coloplast Corp. • Medline Industries • Acelity L.P. • 3M Healthcare • Integra Lifesciences Corp. • Medtronic PLC • Derma Sciences • Systagenix • Mölnlycke Lifesciences Corp. • Organogenesis Inc. • Ethicon Inc. • Paul Hartmann AG • Mimedx Group • Deroyal Industries • Kerecis • Lohmann & Rauscher International GmbH & Co. Kg • Medela AG • Talley Group • Ionmed Inc. (Note: The list of the major players will be updated with the latest market scenario and trends) Wound Care Market Segmentation: By Products • Advanced Wound Care Products o Advanced Wound Dressings o Foam Dressings o Silicone Dressings o Non Silicone Dressings o Hydrocolloid Dressings o Film Dressings o Alginate Dressings o Hydrogel Dressings o Collagen Dressings o Hydrofiber Dressings o Wound Contact Layers o Antimicrobial Dressings o Superabsorbent Dressings o Wound Therapy Devices o Pressure Relief Devices o Wound Assessment & Monitoring Devices o Negative Pressure Wound Therapy Systems o Conventional NPWT Systems o Disposable NPWT Systems o Accessories o Oxygen & Hyperbaric Oxygen Equipment o Electrical Stimulation Devices o Other Therapy Devices o Active Wound Care Products o Biological Skin Substitutes o Human Donor Tissue-derived Products o Acellular Animal-derived Products o Biosynthetic Products o Topical Agents • Surgical Wound Care Products o Sutures o Staplers o Tissue Adhesives, Sealants, & Glues o Fibrin-based Sealants o Collagen-based Sealants o Synthetic Adhesives o Anti-infective Dressings • Traditional Wound Care Products o Medical Tapes o Dressings o Cleansing Agents By Wound Type • Diabetic Foot Ulcers • Pressure Ulcers • Venous Leg Ulcers • Surgical & Traumatic Wounds • Burns • Other Wounds By End User • Hospitals & Clinics • Long-term Care Facilities • Home Care Settings By Region • North America • Latin America • Europe • Asia-Pacific • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Wound Care Market By Product, By Wound Type, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Wound Care Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.
According to the research study conducted by FutureWise research analysts, the Wound Care Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Wound Care Market: • Wuhan Huawei Technology Co. Ltd. • Huizhou Foryou Medical Devices Co. Ltd. • DSHZ Science Technology Co. Ltd. • Smith and Nephew PLC • Convatec Inc. • Coloplast Corp. • Medline Industries • Acelity L.P. • 3M Healthcare • Integra Lifesciences Corp. • Medtronic PLC • Derma Sciences • Systagenix • Mölnlycke Lifesciences Corp. • Organogenesis Inc. • Ethicon Inc. • Paul Hartmann AG • Mimedx Group • Deroyal Industries • Kerecis • Lohmann & Rauscher International GmbH & Co. Kg • Medela AG • Talley Group • Ionmed Inc. (Note: The list of the major players will be updated with the latest market scenario and trends)
Wound Care Market Segmentation:
By Products • Advanced Wound Care Products o Advanced Wound Dressings o Foam Dressings o Silicone Dressings o Non Silicone Dressings o Hydrocolloid Dressings o Film Dressings o Alginate Dressings o Hydrogel Dressings o Collagen Dressings o Hydrofiber Dressings o Wound Contact Layers o Antimicrobial Dressings o Superabsorbent Dressings o Wound Therapy Devices o Pressure Relief Devices o Wound Assessment & Monitoring Devices o Negative Pressure Wound Therapy Systems o Conventional NPWT Systems o Disposable NPWT Systems o Accessories o Oxygen & Hyperbaric Oxygen Equipment o Electrical Stimulation Devices o Other Therapy Devices o Active Wound Care Products o Biological Skin Substitutes o Human Donor Tissue-derived Products o Acellular Animal-derived Products o Biosynthetic Products o Topical Agents • Surgical Wound Care Products o Sutures o Staplers o Tissue Adhesives, Sealants, & Glues o Fibrin-based Sealants o Collagen-based Sealants o Synthetic Adhesives o Anti-infective Dressings • Traditional Wound Care Products o Medical Tapes o Dressings o Cleansing Agents
By Wound Type • Diabetic Foot Ulcers • Pressure Ulcers • Venous Leg Ulcers • Surgical & Traumatic Wounds • Burns • Other Wounds
By End User • Hospitals & Clinics • Long-term Care Facilities • Home Care Settings
By Region • North America • Latin America • Europe • Asia-Pacific • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Wound Care Market By Product, By Wound Type, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Wound Care Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Wound Care Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Wound Care Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Wound Care Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Wound Care Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Advanced Wound Care Products 7.1.1. Advanced Wound Dressings 7.1.1.1. Foam Dressings 7.1.1.1.1. Silicone Dressings 7.1.1.1.2. Non Silicone Dressings 7.1.1.2. Hydrocolloid Dressings 7.1.1.3. Film Dressings 7.1.1.4. Alginate Dressings 7.1.1.5. Hydrogel Dressings 7.1.1.6. Collagen Dressings 7.1.1.7. Hydrofiber Dressings 7.1.1.8. Contact Layers 7.1.1.9. Antimicrobial Dressings 7.1.1.10.Superabsorbent Dressings 7.1.2. Wound Therapy Devices 7.1.2.1. Pressure Relief Devices 7.1.2.2. Wound Assessment & Monitoring Devices 7.1.2.3. Negative Pressure Wound Therapy Systems 7.1.2.3.1. Conventional NPWT Systems 7.1.2.3.2. Disposable NPWT Systems 7.1.2.3.3. Accessories 7.1.2.4. Oxygen & Hyperbaric Oxygen Equipment 7.1.2.5. Electrical Stimulation Devices 7.1.2.6. Other Therapy Devices 7.1.3. Active Wound Care Products 7.1.3.1. Biological Skin Substitutes 7.1.3.1.1. Human Donor Tissue-derived Products 7.1.3.1.2. Acellular Animal-derived Products 7.1.3.1.3. Biosynthetic Products 7.1.3.2. Topical Agents 7.2. Surgical Wound Care Products 7.2.1. Sutures 7.2.2. Staplers 7.2.3. Tissue Adhesives, Sealants, & Glues 7.2.3.1. Fibrin-based Sealants 7.2.3.2. Collagen-based Sealants 7.2.3.4. Synthetic Adhesives 7.2.4. Anti-infective Dressings 7.3. Traditional Wound Care Products 7.3.1. Medical Tapes 7.3.2. Dressings 7.3.3. Cleansing Agents 8. Global Wound Care Market, By Wound Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Diabetic Foot Ulcers 8.2. Pressure Ulcers 8.3. Venous Leg Ulcers 8.4. Surgical & Traumatic Wounds 8.5. Burns 8.6. Other Wounds 9. Global Wound Care Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals & Clinics 9.2. Long-term Care Facilities 9.3. Home Care Settings 10. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Wuhan Huawei Technology Co. Ltd. 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Huizhou Foryou Medical Devices Co. Ltd. 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. DSHZ Science Technology Co. Ltd. 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Smith and Nephew PLC 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Convatec Inc. 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Coloplast Corp. 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Medline Industries 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Acelity L.P. 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. 3M Healthcare 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Integra Lifesciences Corp. 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Medtronic PLC 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Derma Sciences 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. Systagenix 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14. Mölnlycke Lifesciences Corp. 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15. Organogenesis Inc. 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 15.16. Ethicon Inc. 15.16.1. Company Overview 15.16.2. Product Portfolio 15.16.3. SWOT Analysis 15.16.4. Financial Overview 15.16.5. Strategic Overview 15.17. Paul Hartmann AG 15.17.1. Company Overview 15.17.2. Product Portfolio 15.17.3. SWOT Analysis 15.17.4. Financial Overview 15.17.5. Strategic Overview 15.18. Mimedx Group 15.18.1. Company Overview 15.18.2. Product Portfolio 15.18.3. SWOT Analysis 15.18.4. Financial Overview 15.18.5. Strategic Overview 15.19. Deroyal Industries 15.19.1. Company Overview 15.19.2. Product Portfolio 15.19.3. SWOT Analysis 15.19.4. Financial Overview 15.19.5. Strategic Overview 15.20. Kerecis 15.20.1. Company Overview 15.20.2. Product Portfolio 15.20.3. SWOT Analysis 15.20.4. Financial Overview 15.20.5. Strategic Overview 15.21. Lohmann & Rauscher International GmbH & Co. Kg 15.21.1. Company Overview 15.21.2. Product Portfolio 15.21.3. SWOT Analysis 15.21.4. Financial Overview 15.21.5. Strategic Overview 15.22. Medela AG 15.22.1. Company Overview 15.22.2. Product Portfolio 15.22.3. SWOT Analysis 15.22.4. Financial Overview 15.22.5. Strategic Overview 15.23. Talley Group 15.23.1. Company Overview 15.23.2. Product Portfolio 15.23.3. SWOT Analysis 15.23.4. Financial Overview 15.23.5. Strategic Overview 15.24. Ionmed Inc. 15.24.1. Company Overview 15.24.2. Product Portfolio 15.24.3. SWOT Analysis 15.24.4. Financial Overview 15.24.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Wound Care Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Global Wound Care Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Wound Care Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Wound Care Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Wound Care Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Advanced Wound Care Products 7.1.1. Advanced Wound Dressings 7.1.1.1. Foam Dressings 7.1.1.1.1. Silicone Dressings 7.1.1.1.2. Non Silicone Dressings 7.1.1.2. Hydrocolloid Dressings 7.1.1.3. Film Dressings 7.1.1.4. Alginate Dressings 7.1.1.5. Hydrogel Dressings 7.1.1.6. Collagen Dressings 7.1.1.7. Hydrofiber Dressings 7.1.1.8. Contact Layers 7.1.1.9. Antimicrobial Dressings 7.1.1.10.Superabsorbent Dressings 7.1.2. Wound Therapy Devices 7.1.2.1. Pressure Relief Devices 7.1.2.2. Wound Assessment & Monitoring Devices 7.1.2.3. Negative Pressure Wound Therapy Systems 7.1.2.3.1. Conventional NPWT Systems 7.1.2.3.2. Disposable NPWT Systems 7.1.2.3.3. Accessories 7.1.2.4. Oxygen & Hyperbaric Oxygen Equipment 7.1.2.5. Electrical Stimulation Devices 7.1.2.6. Other Therapy Devices 7.1.3. Active Wound Care Products 7.1.3.1. Biological Skin Substitutes 7.1.3.1.1. Human Donor Tissue-derived Products 7.1.3.1.2. Acellular Animal-derived Products 7.1.3.1.3. Biosynthetic Products 7.1.3.2. Topical Agents 7.2. Surgical Wound Care Products 7.2.1. Sutures 7.2.2. Staplers 7.2.3. Tissue Adhesives, Sealants, & Glues 7.2.3.1. Fibrin-based Sealants 7.2.3.2. Collagen-based Sealants 7.2.3.4. Synthetic Adhesives 7.2.4. Anti-infective Dressings 7.3. Traditional Wound Care Products 7.3.1. Medical Tapes 7.3.2. Dressings 7.3.3. Cleansing Agents
8. Global Wound Care Market, By Wound Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Diabetic Foot Ulcers 8.2. Pressure Ulcers 8.3. Venous Leg Ulcers 8.4. Surgical & Traumatic Wounds 8.5. Burns 8.6. Other Wounds
9. Global Wound Care Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals & Clinics 9.2. Long-term Care Facilities 9.3. Home Care Settings
10. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Wuhan Huawei Technology Co. Ltd. 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Huizhou Foryou Medical Devices Co. Ltd. 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. DSHZ Science Technology Co. Ltd. 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Smith and Nephew PLC 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Convatec Inc. 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Coloplast Corp. 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Medline Industries 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Acelity L.P. 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. 3M Healthcare 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Integra Lifesciences Corp. 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Medtronic PLC 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Derma Sciences 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. Systagenix 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14. Mölnlycke Lifesciences Corp. 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15. Organogenesis Inc. 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 15.16. Ethicon Inc. 15.16.1. Company Overview 15.16.2. Product Portfolio 15.16.3. SWOT Analysis 15.16.4. Financial Overview 15.16.5. Strategic Overview 15.17. Paul Hartmann AG 15.17.1. Company Overview 15.17.2. Product Portfolio 15.17.3. SWOT Analysis 15.17.4. Financial Overview 15.17.5. Strategic Overview 15.18. Mimedx Group 15.18.1. Company Overview 15.18.2. Product Portfolio 15.18.3. SWOT Analysis 15.18.4. Financial Overview 15.18.5. Strategic Overview 15.19. Deroyal Industries 15.19.1. Company Overview 15.19.2. Product Portfolio 15.19.3. SWOT Analysis 15.19.4. Financial Overview 15.19.5. Strategic Overview 15.20. Kerecis 15.20.1. Company Overview 15.20.2. Product Portfolio 15.20.3. SWOT Analysis 15.20.4. Financial Overview 15.20.5. Strategic Overview 15.21. Lohmann & Rauscher International GmbH & Co. Kg 15.21.1. Company Overview 15.21.2. Product Portfolio 15.21.3. SWOT Analysis 15.21.4. Financial Overview 15.21.5. Strategic Overview 15.22. Medela AG 15.22.1. Company Overview 15.22.2. Product Portfolio 15.22.3. SWOT Analysis 15.22.4. Financial Overview 15.22.5. Strategic Overview 15.23. Talley Group 15.23.1. Company Overview 15.23.2. Product Portfolio 15.23.3. SWOT Analysis 15.23.4. Financial Overview 15.23.5. Strategic Overview 15.24. Ionmed Inc. 15.24.1. Company Overview 15.24.2. Product Portfolio 15.24.3. SWOT Analysis 15.24.4. Financial Overview 15.24.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics